Cold & Cough Remedies (Pharmacies) - Eastern Africa

Revenue in the Cold & Cough Remedies market is projected to reach US$291.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.83%, resulting in a market volume of US$445.60m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$0.64 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Eastern Africa is experiencing steady growth and development.

Customer preferences: Customers in Eastern Africa have shown a growing preference for over-the-counter cold and cough remedies available at pharmacies. This preference can be attributed to the convenience and accessibility of these products, as well as the increasing awareness and understanding of the benefits of self-medication. Additionally, customers in the region tend to prioritize affordability and effectiveness when choosing cold and cough remedies.

Trends in the market: One notable trend in the Eastern Africa market is the increasing demand for natural and herbal remedies for cold and cough. Customers are becoming more conscious of the potential side effects of conventional medicines and are seeking alternatives that are perceived to be safer and more natural. This trend is driven by the growing popularity of traditional medicine and the cultural belief in the healing power of natural remedies. Another trend in the market is the rising demand for combination cold and cough remedies. Customers are looking for products that can address multiple symptoms simultaneously, such as nasal congestion, cough, and sore throat. This trend is driven by the desire for convenience and efficiency in managing cold and cough symptoms.

Local special circumstances: Eastern Africa is a region with a high prevalence of respiratory infections, including colds and coughs. The climate and environmental conditions in the region, such as dust and pollution, contribute to the frequency and severity of these infections. As a result, the demand for cold and cough remedies is consistently high throughout the year. Furthermore, the healthcare infrastructure in Eastern Africa is still developing, and access to healthcare facilities may be limited in some areas. Pharmacies often serve as the primary point of healthcare for many individuals, making them an important distribution channel for cold and cough remedies.

Underlying macroeconomic factors: The growing population and urbanization in Eastern Africa contribute to the expansion of the cold and cough remedies market. As more people move to cities and towns, the demand for healthcare products, including cold and cough remedies, increases. Additionally, the region is experiencing economic growth, which has led to an improvement in living standards and an increase in disposable income. This enables more individuals to afford cold and cough remedies and other healthcare products. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Eastern Africa is driven by customer preferences for convenient and affordable over-the-counter remedies. The market is characterized by a growing demand for natural and combination products. The high prevalence of respiratory infections and limited healthcare infrastructure in the region contribute to the consistent demand for cold and cough remedies. The macroeconomic factors of population growth, urbanization, and economic development further support the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.